Apr 17 |
Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know
|
Apr 16 |
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
|
Apr 16 |
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
|
Apr 15 |
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
|
Apr 9 |
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
|
Apr 9 |
Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
|
Apr 9 |
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|
Apr 9 |
Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
|
Apr 8 |
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
|
Apr 8 |
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
|